Garde Capital’s Organon & Co OGN Stock Holding History

Garde Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-96	Closed	-$1.43K	–	859
2025 Q1	$1.43K	Buy	+96	New	+$1.48K	﹤0.01%	628

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Garde Capital's OGN Position: Q2 2025 in Review

Garde Capital sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 96 shares — an estimated $1.43K sold.

Garde Capital first reported a position in OGN in Q1 2025 and held it in 1 quarter. The position peaked at $1.43K in Q1 2025. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Garde Capital reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Garde Capital sold 96 Organon & Co shares in Q2 2025, an estimated $1.43K.
Garde Capital first reported a position in Organon & Co in Q1 2025 and held it in 1 quarter.
Garde Capital's Organon & Co position peaked at $1.43K in Q1 2025.
696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Garde Capital's 13F filing for Q2 2025, filed 3 Jul 2025.